Search

everythinglearnresearchcommunity

for

Search:↓

TM-β-CD improves finasteride's solubility and delivery, while β-CD offers better long-term release.

New medications could improve treatment for severe alopecia areata in Australia.

IGF-1 can help regrow hair and may be a promising treatment for hair loss.

Experts created guidelines for who in Australia can get subsidized JAK inhibitor therapy for alopecia areata.

Abraham's family infertility may have a genetic explanation.

VDAC2 promotes cell death in cashmere goat hair follicles through the P53 pathway.

Botanical extract shampoo and tonic improved hair loss in most participants.

Hair specialists vary in testing for alopecia areata, highlighting the need for standard guidelines.

Cyclophosphamide is preferred for severe cases in pediatric rheumatology and nephrology despite its side effects.

PCOS is the most common cause of hirsutism, and personalized treatment is important.

Higher substance P levels may cause discomfort in hair loss patients.

Spironolactone nano-formulations show promise for treating skin disorders, but more research is needed for safety and effectiveness.

Nanoparticles may improve caffeine delivery for hair growth, offering a potential alternative to minoxidil for hair loss treatment.

Ayurvedic treatments can improve symptoms and quality of life for systemic sclerosis patients.

Mesenchymal Stem Cell therapy shows promise for treating hair loss in Alopecia Areata.

Premature graying and hair changes can be treated with certain peptides and possibly targeting the endocannabinoid system.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Lack of sleep in mice leads to prostatitis by reducing certain hormones and activating an inflammatory pathway, which can be temporarily fixed with normal sleep.

Patients with certain skin diseases are willing to spend significant time on treatment, indicating a high impact on their lives and a need for better treatments.

Refugee patients face long wait times for dermatology care, worsening health disparities.

Baricitinib treatment helps regrow eyebrow, eyelash, and scalp hair in severe alopecia areata, improving patients' emotional well-being and quality of life.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

The analysis found that alopecia areata, a hair loss condition, is not very common in Australia, affecting about 0.13% of people, with new cases most often seen in males aged 19 to 34 years.

Cellcurin therapy with microneedling increases hair density and thickness in treating hair loss in men and women.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

Ayurveda can make poisonous plants medicinal through specific purification processes.

Women with frontal fibrosing alopecia have similar vitamin D levels to those with other hair loss types, suggesting vitamin D is not a key factor in this condition.

Certain short peptides can increase root hair growth in tobacco plants.